Scientific Commercialization Revenue and Competitors

Claim your profile

Madison, WI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Scientific Commercialization's estimated annual revenue is currently $3.6M per year.(i)
  • Scientific Commercialization's estimated revenue per employee is $155,000

Employee Data

  • Scientific Commercialization has 23 Employees.(i)
  • Scientific Commercialization grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M167%N/AN/A
#2
$14M90-16%$45.5MN/A
#3
$298.5M19262%N/AN/A
#4
$2.5M160%N/AN/A
#5
$454.5M600230%$1BN/A
#6
$5M32-9%N/AN/A
#7
$2.3M15150%N/AN/A
#8
$3.6M23-15%N/AN/A
#9
$0.6M4-73%N/AN/A
#10
$3.1M2033%N/AN/A

Scientific Commercialization LLC (SC) is a specialized management consulting and business intelligence firm that helps leaders and their organizations optimize performance to achieve measurable, sustainable results. Our life science practice helps pharmaceutical, biopharmaceutical, medical device, and diagnostic companies leverage science to maximize patient success. SC has over 19 years of experience providing strategic guidance, organizational development, and key initiative support in: • Medical Affairs • Field Medical • Research & Development • Clinical Operations • Global Regulatory Affairs • Government Affairs • Commercial Operations Our engagement methodology, tools and techniques deliver tangible value to clients at the conclusion of each well-defined step: 1) Diagnose & Recommend actions to remedy gaps or seize opportunities 2) Plan & Prepare the organization for successful meaningful change 3) Build & Implement high value strategy, process, people or technology solutions and 4) Manage & Measure for ongoing, sustainable performance.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A2315%N/A
#2
$2.3M2392%N/A
#3
$2.3M2321%N/A
#4
$4.9M24N/AN/A
#5
N/A244%N/A